ADRENAL GLAND PHEOCHROMOCYTOMA
Clinical trials for ADRENAL GLAND PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENAL GLAND PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for ADRENAL GLAND PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo targets Hard-to-Treat rare cancers
Disease control OngoingThis study is testing whether a combination of two oral drugs, talazoparib and temozolomide, can shrink advanced rare cancers that have spread and for which standard treatments have stopped working. The trial aims to see if this drug pair can stop tumor growth by damaging cancer …
Matched conditions: ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC